Revolution Medicines Inc (RVMD)

Mar 11, 2025

Revolution Medicines at Barclays Conference: Focus on Pancreatic Cancer Trials - Investing.com UK

Mar 11, 2025

Mar 06, 2025

Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 06, 2025

Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025

Mar 04, 2025

Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs - TipRanks

Mar 04, 2025

Mar 04, 2025

HC Wainwright Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - Defense World

Mar 04, 2025

Mar 03, 2025

Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now - Yahoo Finance

Mar 03, 2025

Mar 03, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 03, 2025

Mar 01, 2025

Long Term Trading Analysis for (RVMD) - Stock Traders Daily

Mar 01, 2025

Mar 01, 2025

Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD) - Defense World

Mar 01, 2025

Feb 28, 2025

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus.com

Feb 28, 2025

Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Feb 27, 2025

Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

Revolution Medicines Inc (RVMD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Feb 27, 2025

Feb 26, 2025

Revolution Medicines Reports 2024 Financial Results and Progress - TipRanks

Feb 26, 2025

Feb 26, 2025

Earnings call transcript: Revolution Medicines Q4 2024 reflects strategic advancements - Investing.com India

Feb 26, 2025

Feb 26, 2025

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewswire

Feb 26, 2025

Feb 26, 2025

Revolution Medicines Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2025

Feb 26, 2025

Revolution Medicines Q4 Net Loss Narrows -February 26, 2025 at 05:13 pm EST - Marketscreener.com

Feb 26, 2025

Feb 26, 2025

Earnings Flash (RVMD) Revolution Medicines Q4 Loss of $1.12 per Share vs. FactSet Est Loss of $0.99 - Marketscreener.com

Feb 26, 2025

Feb 26, 2025

Revolution Medicines, Inc. SEC 10-K Report - TradingView

Feb 26, 2025

Feb 26, 2025

Can Revolution Medicines' $2.3B War Chest Overcome Mounting Losses in Cancer Drug Race? - StockTitan

Feb 26, 2025

Feb 25, 2025

Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 2024 Result - Yahoo Finance

Feb 25, 2025

Feb 24, 2025

Revolution Medicines to Participate in March 2025 Investor Conferences - The Manila Times

Feb 24, 2025

Feb 24, 2025

Can Revolution Medicines' Triple Conference Appearance Signal Major Clinical Updates? - StockTitan

Feb 24, 2025

Feb 24, 2025

Rhumbline Advisers Acquires 24,473 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 24, 2025

Feb 24, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Consensus Target Price from Brokerages - Defense World

Feb 24, 2025

Feb 24, 2025

Revolution Medicines (RVMD) Expected to Announce Earnings on Wednesday - Defense World

Feb 24, 2025

Feb 19, 2025

Revolution Medicines to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - The Manila Times

Feb 19, 2025

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Feb 19, 2025

Feb 19, 2025

Revolution Medicines Q4 Earnings Coming: Will Their Cancer Drug Pipeline Show Progress? - StockTitan

Feb 19, 2025

Feb 19, 2025

(RVMD) Proactive Strategies - Stock Traders Daily

Feb 19, 2025

Feb 17, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN

Feb 17, 2025

Feb 15, 2025

Wilmington Savings Fund Society FSB Sells 15,167 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 15, 2025

SG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 15, 2025

Empowered Funds LLC Purchases New Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 14, 2025

Mirae Asset Global Investments Co. Ltd. Sells 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 14, 2025

Feb 14, 2025

Wingate Wealth Advisors Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 14, 2025

Feb 13, 2025

WCM Investment Management LLC Takes $6.80 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 13, 2025

Feb 10, 2025

Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect? - MSN

Feb 10, 2025

Feb 08, 2025

(RVMD) Trading Advice - Stock Traders Daily

Feb 08, 2025

Feb 08, 2025

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025

Feb 07, 2025

Revolution Medicines Inc [RVMD] stock for 97,443 USD was sold by Cislini Jeff - Knox Daily

Feb 07, 2025

Feb 07, 2025

Stock Performance Spotlight: Revolution Medicines Inc (RVMD) Ends the Day at 43.57, Down by -1.54 - The Dwinnex

Feb 07, 2025

Feb 06, 2025

An analyst sees good growth prospects for Revolution Medicines Inc (RVMD) - SETE News

Feb 06, 2025